{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:43:47Z","timestamp":1790631827063,"version":"4.1.0"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01941","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:51:18Z","timestamp":1566262278000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["Immune Microenvironment of Brain Metastases\u2014Are Microglia and Other Brain Macrophages Little Helpers?"],"prefix":"10.3389","volume":"10","author":[{"given":"Hua","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon","family":"Baluszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozena","family":"Kaminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell."},{"key":"B2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1038\/s41467-018-05346-7","article-title":"Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis","volume":"9","author":"Muliaditan","year":"2018","journal-title":"Nat Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature."},{"key":"B5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/JLB.MR0218-056RR","article-title":"The emerging roles of macrophages in cancer metastasis and response to chemotherapy","volume":"106","author":"Sanchez","year":"2019","journal-title":"J Leukoc Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/sj.bjc.6605373","article-title":"Brain metastases admissions in Sweden between 1987 and 2006","volume":"101","author":"Smedby","year":"2009","journal-title":"Br J Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrn3722","article-title":"Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease","volume":"15","author":"Prinz","year":"2014","journal-title":"Nat Rev Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","article-title":"Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia","volume":"17","author":"Butovsky","year":"2014","journal-title":"Nat Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science."},{"key":"B11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell."},{"key":"B12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fncel.2013.00070","article-title":"Microglia and synapse interactions: fine tuning neural circuits and candidate molecules","volume":"7","author":"Miyamoto","year":"2013","journal-title":"Front Cell Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fncel.2013.00045","article-title":"Origin and differentiation of microglia","volume":"7","author":"Ginhoux","year":"2013","journal-title":"Front Cell Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/glia.22510","article-title":"Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia","volume":"61","author":"Ellert-Miklaszewska","year":"2013","journal-title":"Glia."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.celrep.2016.10.052","article-title":"Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies","volume":"17","author":"Bowman","year":"2016","journal-title":"Cell Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.2923","article-title":"Heterogeneity of CNS myeloid cells and their roles in neurodegeneration","volume":"14","author":"Prinz","year":"2011","journal-title":"Nat Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1158\/0008-5472.CAN-16-2310","article-title":"Cellular and molecular identity of tumor-associated macrophages in glioblastoma","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/labinvest.2017.19","article-title":"Immune microenvironment of gliomas","volume":"97","author":"Gieryng","year":"2017","journal-title":"Lab Investig."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1038\/onc.2016.55","article-title":"Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression","volume":"35","author":"Ellert-Miklaszewska","year":"2016","journal-title":"Oncogene."},{"key":"B20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/neuonc\/nou324","article-title":"Glioma-derived versican promotes tumor expansion via glioma-associated microglial\/macrophages Toll-like receptor 2 signaling","volume":"17","author":"Hu","year":"2015","journal-title":"Neuro Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ncb3090","article-title":"Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth","volume":"17","author":"Zhou","year":"2015","journal-title":"Nat Cell Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1005799805335","article-title":"Hematogenous metastases of the human brain\u2013characteristics of peritumoral brain changes: a review","volume":"35","author":"Zhang","year":"1997","journal-title":"J Neurooncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2015","journal-title":"Nat Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.18632\/oncotarget.2677","article-title":"The landscape of metastatic progression patterns across major human cancers","volume":"6","author":"Budczies","year":"2015","journal-title":"Oncotarget."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/cncr.10541","article-title":"Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma","volume":"94","author":"Schouten","year":"2002","journal-title":"Cancer."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B","article-title":"Central nervous system metastasis from breast carcinoma. Autopsy study","volume":"52","author":"Tsukada","year":"1983","journal-title":"Cancer."},{"key":"B29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/cncr.11859","article-title":"Is breast cancer survival improving? trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000","volume":"100","author":"Giordano","year":"2004","journal-title":"Cancer."},{"key":"B30","first-page":"4655","article-title":"Recent trends in epidemiology of brain metastases: an overview","volume":"32","author":"Tabouret","year":"2012","journal-title":"Anticancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cmonc.2012.07.002","article-title":"Abiraterone increases survival in metastatic prostate cancer","volume":"9","author":"Abraham","year":"2012","journal-title":"Community Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Chaffer","year":"2011","journal-title":"Science."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.4103\/2152-7806.111296","article-title":"Epidemiology and prognosis of brain metastases","volume":"4","author":"Stelzer","year":"2013","journal-title":"Surg Neurol Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1227\/NEU.0b013e31821d31de","article-title":"Outcomes and prognostic factors for patients with brainstem metastases undergoing stereotactic radiosurgery","volume":"69","author":"Hatiboglu","year":"2011","journal-title":"Neurosurgery."},{"key":"B36","doi-asserted-by":"publisher","first-page":"E1540","DOI":"10.1073\/pnas.1714089115","article-title":"Anti-PD-1\/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking","volume":"115","author":"Taggart","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1158\/2326-6066.CIR-18-0067","article-title":"Improved risk-adjusted survival for melanoma brain metastases in the era of checkpoint blockade immunotherapies: results from a national cohort","volume":"6","author":"Iorgulescu","year":"2018","journal-title":"Cancer Immunol Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cncr.30946","article-title":"Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies","volume":"124","author":"Sloot","year":"2018","journal-title":"Cancer."},{"key":"B39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/annonc\/mdv622","article-title":"Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy","volume":"27","author":"Ahmed","year":"2016","journal-title":"Ann Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S0022-3476(83)80583-6","article-title":"Brain metastases in children","volume":"103","author":"Graus","year":"1983","journal-title":"J Pediatr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11060-004-4840-y","article-title":"Brain metastasis in pediatric extracranial solid tumors: survey and literature review","volume":"71","author":"Kebudi","year":"2005","journal-title":"J Neurooncol."},{"key":"B42","volume-title":"Brain Metastases: Advanced Neuroimaging.","author":"Dolgushin","year":"2017"},{"key":"B43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1158\/1541-7786.MCR-18-0601","article-title":"Molecular correlates of metastasis by systematic pan-cancer analysis across the cancer genome atlas","volume":"17","author":"Chen","year":"2018","journal-title":"Mol Cancer Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10585-012-9510-4","article-title":"Characterization of the inflammatory response to solid cancer metastases in the human brain","volume":"30","author":"Berghoff","year":"2013","journal-title":"Clin Exp Metastasis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/cncr.22565","article-title":"Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain","volume":"109","author":"Chen","year":"2007","journal-title":"Cancer."},{"key":"B48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2018.01.067","article-title":"Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey","volume":"93","author":"Levy","year":"2018","journal-title":"Eur J Cancer."},{"key":"B49","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"Prophylactic cranial irradiation in extensive small-cell lung cancer","volume":"357","author":"Slotman","year":"2007","journal-title":"N Engl J Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11060-017-2590-x","article-title":"High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases","volume":"135","author":"Ge","year":"2017","journal-title":"J Neurooncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR -mutated advanced non\u2013small-cell lung cancer","volume":"378","author":"Soria","year":"2017","journal-title":"N Engl J Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1\u2013positive non\u2013small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non\u2013small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med."},{"key":"B55","first-page":"125","article-title":"The monoclonal antibody (MAB) CD 68 allows the immunocytochemical identification of macrophages in primary and metastatic brain tumors in paraffin embedded tissues","volume":"30","author":"Ka\u0142uza","year":"1992","journal-title":"Folia Histochem Cytobiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2119\/2006-00033.He","article-title":"Differential reactions of microglia to brain metastasis of lung cancer","volume":"12","author":"He","year":"2006","journal-title":"Mol Med."},{"key":"B57","first-page":"37","article-title":"Immune cell infiltration of intrinsic and metastatic intracranial tumours","volume":"24","author":"Strik","year":"2004","journal-title":"Anticancer Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11060-016-2216-8","article-title":"Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)","volume":"130","author":"Berghoff","year":"2016","journal-title":"J Neurooncol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1057388","DOI":"10.1080\/2162402X.2015.1057388","article-title":"Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases","volume":"5","author":"Berghoff","year":"2016","journal-title":"Oncoimmunology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ctrv.2018.05.015","article-title":"Non-small cell lung cancer brain metastases and the immune system: from brain metastases development to treatment","volume":"68","author":"El Rassy","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/cncr.23930","article-title":"Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases","volume":"113","author":"Lin","year":"2008","journal-title":"Cancer."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1200\/JCO.2008.19.8481","article-title":"Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases","volume":"27","author":"Leyland-Jones","year":"2009","journal-title":"J Clin Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"P1-17-08","DOI":"10.1158\/1538-7445.SABCS17-P1-17-08","article-title":"P1-17-08. Efficacy of lapatinib and capecitabine combination therapy in brain metastases from HER-2 positive metastatic breast cancer: a systematic review and meta- analysis","volume":"78","author":"Thein","year":"2017","journal-title":"Sabcs."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/glia.21022","article-title":"Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way","volume":"58","author":"Pukrop","year":"2010","journal-title":"Glia."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.2353\/ajpath.2010.090838","article-title":"Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis","volume":"176","author":"Lorger","year":"2010","journal-title":"Am J Pathol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10585-008-9193-z","article-title":"Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization","volume":"25","author":"Fitzgerald","year":"2008","journal-title":"Clin Exp Metastasis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nri3049","article-title":"Homeostatic chemokine receptors and organ-specific metastasis","volume":"11","author":"Zlotnik","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/glia.22518","article-title":"Carcinoma cells misuse the host tissue damage response to invade the brain","volume":"61","author":"Chuang","year":"2013","journal-title":"Glia."},{"key":"B69","doi-asserted-by":"publisher","first-page":"41473","DOI":"10.18632\/oncotarget.9445","article-title":"Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases","volume":"7","author":"Rippaus","year":"2016","journal-title":"Oncotarget."},{"key":"B70","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fonc.2017.00251","article-title":"Anti-inflammatory microglia\/macrophages as a potential therapeutic target in brain metastasis","volume":"7","author":"Andreou","year":"2017","journal-title":"Front Oncol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/neuonc\/not031","article-title":"Premetastatic soil and prevention of breast cancer brain metastasis","volume":"15","author":"Liu","year":"2013","journal-title":"Neuro Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1002\/glia.23485","article-title":"PI3K: a master regulator of brain metastasis-promoting macrophages\/microglia","volume":"66","author":"Blazquez","year":"2018","journal-title":"Glia."},{"key":"B74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.radonc.2014.01.012","article-title":"Low incidence of melanoma brain metastasis in the hippocampus","volume":"111","author":"Hong","year":"2014","journal-title":"Radiother Oncol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/CMR.0000000000000133","article-title":"Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases","volume":"25","author":"Gummadi","year":"2015","journal-title":"Melanoma Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ctrv.2017.01.006","article-title":"Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: a network meta-analysis","volume":"54","author":"Pasquali","year":"2017","journal-title":"Cancer Treat Rev."},{"key":"B78","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-018-0854-5","article-title":"Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter","volume":"17","author":"Redmer","year":"2018","journal-title":"Mol Cancer."},{"key":"B79","first-page":"247","article-title":"Organ-specific metastases in immunodeficient mice injected with human melanoma cells: a quantitative pathological analysis","volume":"3","author":"Byers","year":"1993","journal-title":"Melanoma Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1158\/0008-5472.CAN-08-2588","article-title":"Transforming growth factor- 2 is a molecular determinant for site-specific melanoma metastasis in the brain","volume":"69","author":"Zhang","year":"2009","journal-title":"Cancer Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1158\/0008-5472.CAN-16-0485","article-title":"Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation","volume":"76","author":"Schwartz","year":"2016","journal-title":"Cancer Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12974-018-1389-9","article-title":"Long-term characterization of activated microglia\/macrophages facilitating the development of experimental brain metastasis through intravital microscopic imaging","volume":"16","author":"Qiao","year":"2019","journal-title":"J Neuroinflammation."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/cncr.24203","article-title":"Intracranial dural metastases","volume":"115","author":"Nayak","year":"2009","journal-title":"Cancer."},{"key":"B84","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/CCO.0b013e32833de986","article-title":"Leptomeningeal metastasis","volume":"22","author":"Chamberlain","year":"2010","journal-title":"Curr Opin Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jocn.2015.11.012","article-title":"Management of leptomeningeal metastases: prognostic factors and associated outcomes","volume":"27","author":"Brower","year":"2016","journal-title":"J Clin Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","article-title":"EANO\u2013ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours","volume":"28","author":"Le Rhun","year":"2017","journal-title":"Ann Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ni.3423","article-title":"Origin, fate and dynamics of macrophages at central nervous system interfaces","volume":"17","author":"Goldmann","year":"2016","journal-title":"Nat Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1046\/j.0953-816x.2001.01793.x","article-title":"Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages","volume":"14","author":"Bechmann","year":"2001","journal-title":"Eur J Neurosci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11912-005-0026-9","article-title":"Metastatic neurologic complications of non-Hodgkin's lymphoma","volume":"7","author":"Grier","year":"2005","journal-title":"Curr Oncol Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1200\/JCO.2003.08.047","article-title":"CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials","volume":"21","author":"Clarke","year":"2003","journal-title":"J Clin Oncol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1189\/jlb.5MA0915-394R","article-title":"Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia","volume":"99","author":"Jost","year":"2016","journal-title":"J Leukoc Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41586-018-0342-5","article-title":"Leukaemia hijacks a neural mechanism to invade the central nervous system","volume":"560","author":"Yao","year":"2018","journal-title":"Nature."},{"key":"B93","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00401-016-1536-2","article-title":"Genomic characterization of primary central nervous system lymphoma","volume":"131","author":"Fukumura","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/annonc\/mdv076","article-title":"First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)-a systematic review and individual patient data meta-analysis","volume":"26","author":"Kasenda","year":"2015","journal-title":"Ann Oncol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00401-016-1664-8","article-title":"Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma","volume":"133","author":"Nakamura","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3960\/jslrt.51.93","article-title":"M2 macrophage\/microglial cells induce activation of Stat3 in primary central nervous system lymphoma","volume":"51","author":"Komohara","year":"2011","journal-title":"J Clin Exp Hematop."},{"key":"B97","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/bpa.12318","article-title":"Tumor-associated macrophages associate with cerebrospinal fluid interleukin-10 and survival in primary central nervous system lymphoma (PCNSL)","volume":"26","author":"Sasayama","year":"2016","journal-title":"Brain Pathol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/neuonc\/nor203","article-title":"Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)","volume":"14","author":"Sasayama","year":"2012","journal-title":"Neuro Oncol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"38671","DOI":"10.1038\/srep38671","article-title":"Cerebrospinal fluid IL-10 and IL-10\/IL-6 as accurate diagnostic biomarkers for primary central nervous system large B-cell lymphoma","volume":"6","author":"Song","year":"2016","journal-title":"Sci Rep."},{"key":"B100","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2016.03.080","article-title":"The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients","volume":"61","author":"Nguyen-Them","year":"2016","journal-title":"Eur J Cancer."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e1442164","DOI":"10.1080\/2162402X.2018.1442164","article-title":"Prognostic implications of tumor-infiltrating macrophages, M2 macrophages, regulatory T-cells, and indoleamine 2,3-dioxygenase-positive cells in primary diffuse large B-cell lymphoma of the central nervous system","volume":"7","author":"Nam","year":"2018","journal-title":"Oncoimmunology."},{"key":"B102","doi-asserted-by":"publisher","first-page":"32156","DOI":"10.18632\/oncotarget.8537","article-title":"Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma","volume":"7","author":"Yushi","year":"2016","journal-title":"Oncotarget."},{"key":"B103","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3892\/ol.2017.6122","article-title":"Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma","volume":"14","author":"Takahashi","year":"2017","journal-title":"Oncol Lett."},{"key":"B104","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1182\/blood-2008-04-152835","article-title":"Differential gene expression in central nervous system lymphoma","volume":"113","author":"Rubenstein","year":"2009","journal-title":"Blood."},{"key":"B105","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/NEN.0b013e31828b7a98","article-title":"Mechanisms of intracerebral lymphoma growth delineated in a syngeneic mouse model of central nervous system lymphoma","volume":"72","author":"Montesinos-Rongen","year":"2013","journal-title":"J Neuropathol Exp Neurol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood."},{"key":"B107","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1182\/blood-2017-01-764209","article-title":"PD-1 blockade with nivolumab in relapsed\/refractory primary central nervous system and testicular lymphoma","volume":"129","author":"Nayak","year":"2017","journal-title":"Blood."},{"key":"B108","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.21873\/anticanres.12001","article-title":"Programmed cell death ligand 1 expression in primary central nervous system lymphomas: a clinicopathological study","volume":"37","author":"Hayano","year":"2017","journal-title":"Anticancer Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10555-018-9766-5","article-title":"Perspectives on the role of brain cellular players in cancer-associated brain metastasis: translational approach to understand molecular mechanism of tumor progression","volume":"37","author":"Raza","year":"2018","journal-title":"Cancer Metastasis Rev."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01941\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:51:39Z","timestamp":1566262299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01941\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":109,"alternative-id":["10.3389\/fimmu.2019.01941"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01941","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1007\/s11060-025-05379-1","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]},"article-number":"1941"}}